Fortrea
Kim Berdan, CPA, currently serves as the Americas Controller at Fortrea since May 2023. Prior to this role, Kim held the position of Americas Controller for Clinical Development Services at Labcorp Drug Development from October 2009 to May 2023. Kim's career includes significant experience as a Controller at Arbinet and as a Financial Reporting Manager at AT&T. Additionally, Kim worked as a Finance Manager at Revlon and APBNEWS. The early career featured a role as a Supervising Audit Consultant at Grant Thornton. Kim Berdan holds a Bachelor’s degree in Accounting from St. John's University, obtained between 1989 and 1993.
This person is not in any teams
This person is not in any offices
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.